Mark P. Frissora - 01 Jun 2026 Form 4 Insider Report for BIOADAPTIVES, INC. (BDPT)

Reporting relationship: Director
Issuer ticker: BDPT
Reported as of: 01 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2026, 21:03:38 UTC
Prior SEC filing: 05 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark P. Frissora

Key filing fact

Mark P. Frissora filed Form 4 for BIOADAPTIVES, INC. (BDPT) on 03 Jun 2026.

Key facts

This page summarizes Mark P. Frissora's Form 4 filing for BIOADAPTIVES, INC. (BDPT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jun 2026, 21:03.

Change

Previous filing in this sequence was filed on 05 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001239786 Primary reporting owner

FRISSORA MARK P

Relationship: Director
Address: C/O BIOADAPTIVES, INC., 2620 REGATTA DRIVE, SUITE 102, LAS VEGAS
Signature: /s/ Mark P. Frissora
Signature date: 03 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BDPT transaction Derivative

Series D Convertible Preferred Stock

Other

Transaction value
Shares: +4,717
Change %: +6.6%
Price: $0.000000^*
Shares after: 76,271
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 471,700
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of Series D Convertible Preferred Stock issued as compensation for board services pursuant to that certain Board of Directors Agreement, dated February 3, 2025, between the Issuer and the Reporting Person.

Footnote F2

The Reporting Person's shares of Series D Convertible Preferred Stock, par value $0.0001 per share, are convertible into shares of common stock, par value $0.0001 per share, at a ratio of 100 shares of common stock for each share of Series D Convertible Preferred Stock, subject to a 4.9% beneficial ownership limitation. No shares of Series D Convertible Preferred Stock may be converted until six months after the date of issuance, except in the case of liquidation, whereupon the conversion will occur immediately. Each share of Series D Convertible Preferred Stock outstanding at the time of a meeting of stockholders or a solicitation of consent is entitled to 100 votes on matters of the Issuer, without regard to the beneficial ownership limitation. The right to convert does not expire.

SEC remarks

None.